Silver Book Fact

Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349 in women 50- to 59-years-old, and $74,981 in women 60 to 69.

Joint Economic Committee. The Benefits of Medical Research and the Role of NIH. Apr-2000;

Reference

Title
The Benefits of Medical Research and the Role of NIH
Publisher
United States Senate: Office of the Chairman, Connie Mack
Publication Date
Apr-2000
Authors
Joint Economic Committee

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Since the war on cancer was declared in 1971, our arsenal has tripled. New drugs accounted for around 50-60% of the increase in six-year cancer survival rates since 1975.…  
  • According to the Pharmaceutical Research and Manufacturers of America, a radiopharmaceutical currently in development is a synthetic version of a substance derived from scorpions–chlorotoxin. This could be a powerful…  
  • “If you had been diagnosed with chronic myeloid leukemia (CML) in 1999, chances were that you would not be alive today. Just 3 out of 10 patients survived for…  
  • Incidence rates for colorectal cancer have been decreasing since 1985, from 66 to 52 per 100,000 in 2002.